Previous studies found that TNFR2, but not TNFR1, were the predominant TNF receptor on CD8+ effector T cells (67, 68); the proportion of proliferating transgenic tumor-specific CD8+ T cells in TNFR2 deficient mice was significantly reduced in TDLNs (67). Here, TNFRSF1B is linked to neoplasm.